| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $54.5M | — | +49.5% |
| SG&A Expense | $15.5M | — | +40.7% |
| Operating Income | -$70.0M | — | -47.5% |
| Income Tax | $622K | — | +306.5% |
| Net Income | -$69.7M | — | -74.5% |
| EPS (Basic) | -$0.98 | — | -55.6% |
| EPS (Diluted) | -$0.98 | — | -55.6% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $298.5M | -10.8% | +9.9% |
| Current Assets | $396.6M | -5.9% | -21.7% |
| Total Assets | $400.4M | -5.7% | -21.7% |
| Current Liabilities | $46.1M | +1.4% | +92.3% |
| Long-term Debt | $99.0M | +33.6% | +35.6% |
| Total Liabilities | $146.3M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$66.3M | — | -73.8% |
| Capital Expenditures | $0 | — | -100.0% |
| Investing Cash Flow | $98K | — | -99.8% |
| Financing Cash Flow | $30.6M | — | -58.1% |
| Free Cash Flow | -$66.3M | — | -73.6% |
| +48.3% |
| Stockholders' Equity | $254.0M | -16.6% | -37.7% |